nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyurea—RRM2—embryo—testicular cancer	0.0135	0.171	CbGeAlD
Hydroxyurea—RRM2—Vinorelbine—Vinblastine—testicular cancer	0.0131	1	CbGdCrCtD
Hydroxyurea—RRM1—seminal vesicle—testicular cancer	0.0106	0.134	CbGeAlD
Hydroxyurea—RRM2—gonad—testicular cancer	0.00919	0.116	CbGeAlD
Hydroxyurea—RRM1—gonad—testicular cancer	0.00764	0.0966	CbGeAlD
Hydroxyurea—RRM2—female gonad—testicular cancer	0.00747	0.0945	CbGeAlD
Hydroxyurea—RRM2—testis—testicular cancer	0.00663	0.0838	CbGeAlD
Hydroxyurea—RRM1—female gonad—testicular cancer	0.00621	0.0785	CbGeAlD
Hydroxyurea—RRM1—testis—testicular cancer	0.0055	0.0696	CbGeAlD
Hydroxyurea—RRM2—lymph node—testicular cancer	0.0048	0.0608	CbGeAlD
Hydroxyurea—RRM1—lymph node—testicular cancer	0.00399	0.0505	CbGeAlD
Hydroxyurea—CYP2D6—female gonad—testicular cancer	0.00184	0.0233	CbGeAlD
Hydroxyurea—CYP2D6—testis—testicular cancer	0.00164	0.0207	CbGeAlD
Hydroxyurea—Vomiting—Chlorambucil—testicular cancer	0.000642	0.000707	CcSEcCtD
Hydroxyurea—Anorexia—Ifosfamide—testicular cancer	0.000636	0.000701	CcSEcCtD
Hydroxyurea—Malaise—Cisplatin—testicular cancer	0.000636	0.0007	CcSEcCtD
Hydroxyurea—Decreased appetite—Dactinomycin—testicular cancer	0.000633	0.000698	CcSEcCtD
Hydroxyurea—Diarrhoea—Vinblastine—testicular cancer	0.000633	0.000697	CcSEcCtD
Hydroxyurea—Leukopenia—Cisplatin—testicular cancer	0.000631	0.000695	CcSEcCtD
Hydroxyurea—Dermatitis bullous—Epirubicin—testicular cancer	0.000629	0.000693	CcSEcCtD
Hydroxyurea—Fatigue—Dactinomycin—testicular cancer	0.000628	0.000692	CcSEcCtD
Hydroxyurea—Pain—Dactinomycin—testicular cancer	0.000623	0.000686	CcSEcCtD
Hydroxyurea—Hepatic failure—Doxorubicin—testicular cancer	0.000619	0.000682	CcSEcCtD
Hydroxyurea—Body temperature increased—Bleomycin—testicular cancer	0.000617	0.00068	CcSEcCtD
Hydroxyurea—Dizziness—Vinblastine—testicular cancer	0.000612	0.000674	CcSEcCtD
Hydroxyurea—Convulsion—Cisplatin—testicular cancer	0.000611	0.000673	CcSEcCtD
Hydroxyurea—Renal failure acute—Doxorubicin—testicular cancer	0.000603	0.000664	CcSEcCtD
Hydroxyurea—Feeling abnormal—Dactinomycin—testicular cancer	0.0006	0.000661	CcSEcCtD
Hydroxyurea—Nausea—Chlorambucil—testicular cancer	0.000599	0.00066	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Etoposide—testicular cancer	0.000599	0.00066	CcSEcCtD
Hydroxyurea—Anaemia—Etoposide—testicular cancer	0.000597	0.000658	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000596	0.000657	CcSEcCtD
Hydroxyurea—Dyspnoea—Ifosfamide—testicular cancer	0.000595	0.000656	CcSEcCtD
Hydroxyurea—Somnolence—Ifosfamide—testicular cancer	0.000593	0.000654	CcSEcCtD
Hydroxyurea—Discomfort—Cisplatin—testicular cancer	0.000593	0.000653	CcSEcCtD
Hydroxyurea—Vomiting—Vinblastine—testicular cancer	0.000588	0.000648	CcSEcCtD
Hydroxyurea—Malaise—Etoposide—testicular cancer	0.000583	0.000642	CcSEcCtD
Hydroxyurea—Dermatitis bullous—Doxorubicin—testicular cancer	0.000582	0.000641	CcSEcCtD
Hydroxyurea—Breast disorder—Methotrexate—testicular cancer	0.000581	0.00064	CcSEcCtD
Hydroxyurea—Face oedema—Epirubicin—testicular cancer	0.000581	0.000639	CcSEcCtD
Hydroxyurea—Decreased appetite—Ifosfamide—testicular cancer	0.00058	0.000639	CcSEcCtD
Hydroxyurea—Headache—Vinblastine—testicular cancer	0.000579	0.000638	CcSEcCtD
Hydroxyurea—Leukopenia—Etoposide—testicular cancer	0.000578	0.000637	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000576	0.000635	CcSEcCtD
Hydroxyurea—Body temperature increased—Dactinomycin—testicular cancer	0.000576	0.000634	CcSEcCtD
Hydroxyurea—Fatigue—Ifosfamide—testicular cancer	0.000576	0.000634	CcSEcCtD
Hydroxyurea—Oedema—Cisplatin—testicular cancer	0.000575	0.000634	CcSEcCtD
Hydroxyurea—Hypersensitivity—Bleomycin—testicular cancer	0.000575	0.000634	CcSEcCtD
Hydroxyurea—Infection—Cisplatin—testicular cancer	0.000572	0.00063	CcSEcCtD
Hydroxyurea—Pain—Ifosfamide—testicular cancer	0.000571	0.000629	CcSEcCtD
Hydroxyurea—Constipation—Ifosfamide—testicular cancer	0.000571	0.000629	CcSEcCtD
Hydroxyurea—Nervous system disorder—Cisplatin—testicular cancer	0.000564	0.000622	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Cisplatin—testicular cancer	0.000563	0.000621	CcSEcCtD
Hydroxyurea—Blood creatinine increased—Epirubicin—testicular cancer	0.000563	0.00062	CcSEcCtD
Hydroxyurea—Asthenia—Bleomycin—testicular cancer	0.00056	0.000617	CcSEcCtD
Hydroxyurea—Convulsion—Etoposide—testicular cancer	0.00056	0.000617	CcSEcCtD
Hydroxyurea—Skin disorder—Cisplatin—testicular cancer	0.000559	0.000616	CcSEcCtD
Hydroxyurea—Feeling abnormal—Ifosfamide—testicular cancer	0.00055	0.000606	CcSEcCtD
Hydroxyurea—Nausea—Vinblastine—testicular cancer	0.000549	0.000605	CcSEcCtD
Hydroxyurea—Anorexia—Cisplatin—testicular cancer	0.000549	0.000604	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000546	0.000602	CcSEcCtD
Hydroxyurea—Pancreatitis—Methotrexate—testicular cancer	0.000544	0.0006	CcSEcCtD
Hydroxyurea—Discomfort—Etoposide—testicular cancer	0.000543	0.000599	CcSEcCtD
Hydroxyurea—Breast disorder—Epirubicin—testicular cancer	0.000543	0.000599	CcSEcCtD
Hydroxyurea—Face oedema—Doxorubicin—testicular cancer	0.000537	0.000592	CcSEcCtD
Hydroxyurea—Hypersensitivity—Dactinomycin—testicular cancer	0.000537	0.000591	CcSEcCtD
Hydroxyurea—Body temperature increased—Ifosfamide—testicular cancer	0.000528	0.000581	CcSEcCtD
Hydroxyurea—Pancytopenia—Methotrexate—testicular cancer	0.000527	0.000581	CcSEcCtD
Hydroxyurea—Infection—Etoposide—testicular cancer	0.000524	0.000577	CcSEcCtD
Hydroxyurea—Asthenia—Dactinomycin—testicular cancer	0.000523	0.000576	CcSEcCtD
Hydroxyurea—Blood creatinine increased—Doxorubicin—testicular cancer	0.000521	0.000574	CcSEcCtD
Hydroxyurea—Dysuria—Methotrexate—testicular cancer	0.000519	0.000572	CcSEcCtD
Hydroxyurea—Neutropenia—Methotrexate—testicular cancer	0.000519	0.000572	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Etoposide—testicular cancer	0.000516	0.000569	CcSEcCtD
Hydroxyurea—Dyspnoea—Cisplatin—testicular cancer	0.000513	0.000565	CcSEcCtD
Hydroxyurea—Skin disorder—Etoposide—testicular cancer	0.000512	0.000564	CcSEcCtD
Hydroxyurea—Pancreatitis—Epirubicin—testicular cancer	0.00051	0.000561	CcSEcCtD
Hydroxyurea—Breast disorder—Doxorubicin—testicular cancer	0.000503	0.000554	CcSEcCtD
Hydroxyurea—Anorexia—Etoposide—testicular cancer	0.000503	0.000554	CcSEcCtD
Hydroxyurea—Decreased appetite—Cisplatin—testicular cancer	0.0005	0.000551	CcSEcCtD
Hydroxyurea—Diarrhoea—Dactinomycin—testicular cancer	0.000498	0.000549	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000497	0.000547	CcSEcCtD
Hydroxyurea—Vomiting—Bleomycin—testicular cancer	0.000497	0.000547	CcSEcCtD
Hydroxyurea—Infestation—Methotrexate—testicular cancer	0.000495	0.000545	CcSEcCtD
Hydroxyurea—Drowsiness—Methotrexate—testicular cancer	0.000495	0.000545	CcSEcCtD
Hydroxyurea—Infestation NOS—Methotrexate—testicular cancer	0.000495	0.000545	CcSEcCtD
Hydroxyurea—Pancytopenia—Epirubicin—testicular cancer	0.000494	0.000544	CcSEcCtD
Hydroxyurea—Rash—Bleomycin—testicular cancer	0.000492	0.000542	CcSEcCtD
Hydroxyurea—Pain—Cisplatin—testicular cancer	0.000492	0.000542	CcSEcCtD
Hydroxyurea—Dermatitis—Bleomycin—testicular cancer	0.000492	0.000542	CcSEcCtD
Hydroxyurea—Hypersensitivity—Ifosfamide—testicular cancer	0.000492	0.000542	CcSEcCtD
Hydroxyurea—Neutropenia—Epirubicin—testicular cancer	0.000486	0.000535	CcSEcCtD
Hydroxyurea—Dysuria—Epirubicin—testicular cancer	0.000486	0.000535	CcSEcCtD
Hydroxyurea—Stomatitis—Methotrexate—testicular cancer	0.000483	0.000532	CcSEcCtD
Hydroxyurea—Asthenia—Ifosfamide—testicular cancer	0.000479	0.000528	CcSEcCtD
Hydroxyurea—Feeling abnormal—Cisplatin—testicular cancer	0.000474	0.000522	CcSEcCtD
Hydroxyurea—Weight increased—Epirubicin—testicular cancer	0.000473	0.000521	CcSEcCtD
Hydroxyurea—Pancreatitis—Doxorubicin—testicular cancer	0.000471	0.000519	CcSEcCtD
Hydroxyurea—Dyspnoea—Etoposide—testicular cancer	0.00047	0.000518	CcSEcCtD
Hydroxyurea—Somnolence—Etoposide—testicular cancer	0.000469	0.000516	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Methotrexate—testicular cancer	0.000468	0.000516	CcSEcCtD
Hydroxyurea—Nausea—Bleomycin—testicular cancer	0.000464	0.000511	CcSEcCtD
Hydroxyurea—Infestation NOS—Epirubicin—testicular cancer	0.000463	0.00051	CcSEcCtD
Hydroxyurea—Drowsiness—Epirubicin—testicular cancer	0.000463	0.00051	CcSEcCtD
Hydroxyurea—Infestation—Epirubicin—testicular cancer	0.000463	0.00051	CcSEcCtD
Hydroxyurea—Vomiting—Dactinomycin—testicular cancer	0.000463	0.00051	CcSEcCtD
Hydroxyurea—Rash—Dactinomycin—testicular cancer	0.000459	0.000506	CcSEcCtD
Hydroxyurea—Decreased appetite—Etoposide—testicular cancer	0.000458	0.000505	CcSEcCtD
Hydroxyurea—Diarrhoea—Ifosfamide—testicular cancer	0.000457	0.000503	CcSEcCtD
Hydroxyurea—Pancytopenia—Doxorubicin—testicular cancer	0.000457	0.000503	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Etoposide—testicular cancer	0.000455	0.000501	CcSEcCtD
Hydroxyurea—Body temperature increased—Cisplatin—testicular cancer	0.000455	0.000501	CcSEcCtD
Hydroxyurea—Fatigue—Etoposide—testicular cancer	0.000455	0.000501	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Epirubicin—testicular cancer	0.000454	0.0005	CcSEcCtD
Hydroxyurea—Stomatitis—Epirubicin—testicular cancer	0.000452	0.000498	CcSEcCtD
Hydroxyurea—Constipation—Etoposide—testicular cancer	0.000451	0.000497	CcSEcCtD
Hydroxyurea—Pain—Etoposide—testicular cancer	0.000451	0.000497	CcSEcCtD
Hydroxyurea—Dysuria—Doxorubicin—testicular cancer	0.00045	0.000495	CcSEcCtD
Hydroxyurea—Neutropenia—Doxorubicin—testicular cancer	0.00045	0.000495	CcSEcCtD
Hydroxyurea—Haemoglobin—Methotrexate—testicular cancer	0.000447	0.000492	CcSEcCtD
Hydroxyurea—Haemorrhage—Methotrexate—testicular cancer	0.000445	0.00049	CcSEcCtD
Hydroxyurea—Dizziness—Ifosfamide—testicular cancer	0.000441	0.000486	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Epirubicin—testicular cancer	0.000438	0.000483	CcSEcCtD
Hydroxyurea—Weight increased—Doxorubicin—testicular cancer	0.000438	0.000482	CcSEcCtD
Hydroxyurea—Feeling abnormal—Etoposide—testicular cancer	0.000434	0.000479	CcSEcCtD
Hydroxyurea—Nausea—Dactinomycin—testicular cancer	0.000433	0.000477	CcSEcCtD
Hydroxyurea—Drowsiness—Doxorubicin—testicular cancer	0.000429	0.000472	CcSEcCtD
Hydroxyurea—Infestation—Doxorubicin—testicular cancer	0.000429	0.000472	CcSEcCtD
Hydroxyurea—Infestation NOS—Doxorubicin—testicular cancer	0.000429	0.000472	CcSEcCtD
Hydroxyurea—Vomiting—Ifosfamide—testicular cancer	0.000424	0.000467	CcSEcCtD
Hydroxyurea—Hypersensitivity—Cisplatin—testicular cancer	0.000424	0.000467	CcSEcCtD
Hydroxyurea—Rash—Ifosfamide—testicular cancer	0.000421	0.000464	CcSEcCtD
Hydroxyurea—Dermatitis—Ifosfamide—testicular cancer	0.000421	0.000463	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Doxorubicin—testicular cancer	0.00042	0.000463	CcSEcCtD
Hydroxyurea—Haemoglobin—Epirubicin—testicular cancer	0.000418	0.000461	CcSEcCtD
Hydroxyurea—Stomatitis—Doxorubicin—testicular cancer	0.000418	0.00046	CcSEcCtD
Hydroxyurea—Body temperature increased—Etoposide—testicular cancer	0.000417	0.000459	CcSEcCtD
Hydroxyurea—Haemorrhage—Epirubicin—testicular cancer	0.000416	0.000458	CcSEcCtD
Hydroxyurea—Asthenia—Cisplatin—testicular cancer	0.000413	0.000455	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000405	0.000447	CcSEcCtD
Hydroxyurea—Angiopathy—Methotrexate—testicular cancer	0.000403	0.000444	CcSEcCtD
Hydroxyurea—Chills—Methotrexate—testicular cancer	0.000399	0.000439	CcSEcCtD
Hydroxyurea—Nausea—Ifosfamide—testicular cancer	0.000397	0.000437	CcSEcCtD
Hydroxyurea—Diarrhoea—Cisplatin—testicular cancer	0.000394	0.000434	CcSEcCtD
Hydroxyurea—Alopecia—Methotrexate—testicular cancer	0.000393	0.000433	CcSEcCtD
Hydroxyurea—Hypersensitivity—Etoposide—testicular cancer	0.000388	0.000428	CcSEcCtD
Hydroxyurea—Erythema—Methotrexate—testicular cancer	0.000387	0.000426	CcSEcCtD
Hydroxyurea—Haemoglobin—Doxorubicin—testicular cancer	0.000387	0.000426	CcSEcCtD
Hydroxyurea—Haemorrhage—Doxorubicin—testicular cancer	0.000385	0.000424	CcSEcCtD
Hydroxyurea—Asthenia—Etoposide—testicular cancer	0.000378	0.000417	CcSEcCtD
Hydroxyurea—Angiopathy—Epirubicin—testicular cancer	0.000377	0.000416	CcSEcCtD
Hydroxyurea—Chills—Epirubicin—testicular cancer	0.000373	0.000411	CcSEcCtD
Hydroxyurea—Alopecia—Epirubicin—testicular cancer	0.000368	0.000405	CcSEcCtD
Hydroxyurea—Vomiting—Cisplatin—testicular cancer	0.000366	0.000403	CcSEcCtD
Hydroxyurea—Rash—Cisplatin—testicular cancer	0.000363	0.0004	CcSEcCtD
Hydroxyurea—Dermatitis—Cisplatin—testicular cancer	0.000363	0.000399	CcSEcCtD
Hydroxyurea—Erythema—Epirubicin—testicular cancer	0.000362	0.000399	CcSEcCtD
Hydroxyurea—Diarrhoea—Etoposide—testicular cancer	0.000361	0.000397	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Methotrexate—testicular cancer	0.000359	0.000395	CcSEcCtD
Hydroxyurea—Anaemia—Methotrexate—testicular cancer	0.000358	0.000394	CcSEcCtD
Hydroxyurea—Angiopathy—Doxorubicin—testicular cancer	0.000349	0.000385	CcSEcCtD
Hydroxyurea—Malaise—Methotrexate—testicular cancer	0.000349	0.000384	CcSEcCtD
Hydroxyurea—Dizziness—Etoposide—testicular cancer	0.000349	0.000384	CcSEcCtD
Hydroxyurea—Leukopenia—Methotrexate—testicular cancer	0.000346	0.000382	CcSEcCtD
Hydroxyurea—Chills—Doxorubicin—testicular cancer	0.000345	0.00038	CcSEcCtD
Hydroxyurea—Nausea—Cisplatin—testicular cancer	0.000342	0.000377	CcSEcCtD
Hydroxyurea—Alopecia—Doxorubicin—testicular cancer	0.00034	0.000375	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Epirubicin—testicular cancer	0.000336	0.00037	CcSEcCtD
Hydroxyurea—Convulsion—Methotrexate—testicular cancer	0.000335	0.000369	CcSEcCtD
Hydroxyurea—Vomiting—Etoposide—testicular cancer	0.000335	0.000369	CcSEcCtD
Hydroxyurea—Erythema—Doxorubicin—testicular cancer	0.000335	0.000369	CcSEcCtD
Hydroxyurea—Anaemia—Epirubicin—testicular cancer	0.000335	0.000369	CcSEcCtD
Hydroxyurea—Rash—Etoposide—testicular cancer	0.000332	0.000366	CcSEcCtD
Hydroxyurea—Dermatitis—Etoposide—testicular cancer	0.000332	0.000366	CcSEcCtD
Hydroxyurea—Headache—Etoposide—testicular cancer	0.00033	0.000364	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000327	0.00036	CcSEcCtD
Hydroxyurea—Malaise—Epirubicin—testicular cancer	0.000327	0.00036	CcSEcCtD
Hydroxyurea—Discomfort—Methotrexate—testicular cancer	0.000325	0.000359	CcSEcCtD
Hydroxyurea—Leukopenia—Epirubicin—testicular cancer	0.000324	0.000357	CcSEcCtD
Hydroxyurea—Convulsion—Epirubicin—testicular cancer	0.000314	0.000346	CcSEcCtD
Hydroxyurea—Infection—Methotrexate—testicular cancer	0.000314	0.000346	CcSEcCtD
Hydroxyurea—Nausea—Etoposide—testicular cancer	0.000313	0.000345	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Doxorubicin—testicular cancer	0.000311	0.000342	CcSEcCtD
Hydroxyurea—Nervous system disorder—Methotrexate—testicular cancer	0.00031	0.000341	CcSEcCtD
Hydroxyurea—Anaemia—Doxorubicin—testicular cancer	0.00031	0.000341	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Methotrexate—testicular cancer	0.000309	0.000341	CcSEcCtD
Hydroxyurea—Skin disorder—Methotrexate—testicular cancer	0.000307	0.000338	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000306	0.000337	CcSEcCtD
Hydroxyurea—Discomfort—Epirubicin—testicular cancer	0.000305	0.000336	CcSEcCtD
Hydroxyurea—Malaise—Doxorubicin—testicular cancer	0.000302	0.000333	CcSEcCtD
Hydroxyurea—Anorexia—Methotrexate—testicular cancer	0.000301	0.000332	CcSEcCtD
Hydroxyurea—Leukopenia—Doxorubicin—testicular cancer	0.0003	0.00033	CcSEcCtD
Hydroxyurea—Oedema—Epirubicin—testicular cancer	0.000296	0.000326	CcSEcCtD
Hydroxyurea—Infection—Epirubicin—testicular cancer	0.000294	0.000323	CcSEcCtD
Hydroxyurea—Convulsion—Doxorubicin—testicular cancer	0.00029	0.00032	CcSEcCtD
Hydroxyurea—Nervous system disorder—Epirubicin—testicular cancer	0.00029	0.000319	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Epirubicin—testicular cancer	0.000289	0.000319	CcSEcCtD
Hydroxyurea—Skin disorder—Epirubicin—testicular cancer	0.000287	0.000316	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000283	0.000312	CcSEcCtD
Hydroxyurea—Discomfort—Doxorubicin—testicular cancer	0.000282	0.00031	CcSEcCtD
Hydroxyurea—Anorexia—Epirubicin—testicular cancer	0.000282	0.00031	CcSEcCtD
Hydroxyurea—Dyspnoea—Methotrexate—testicular cancer	0.000282	0.00031	CcSEcCtD
Hydroxyurea—Somnolence—Methotrexate—testicular cancer	0.000281	0.000309	CcSEcCtD
Hydroxyurea—Dyspepsia—Methotrexate—testicular cancer	0.000278	0.000306	CcSEcCtD
Hydroxyurea—Decreased appetite—Methotrexate—testicular cancer	0.000275	0.000302	CcSEcCtD
Hydroxyurea—Oedema—Doxorubicin—testicular cancer	0.000273	0.000301	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000273	0.0003	CcSEcCtD
Hydroxyurea—Fatigue—Methotrexate—testicular cancer	0.000272	0.0003	CcSEcCtD
Hydroxyurea—Infection—Doxorubicin—testicular cancer	0.000272	0.000299	CcSEcCtD
Hydroxyurea—Pain—Methotrexate—testicular cancer	0.00027	0.000297	CcSEcCtD
Hydroxyurea—Nervous system disorder—Doxorubicin—testicular cancer	0.000268	0.000295	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Doxorubicin—testicular cancer	0.000268	0.000295	CcSEcCtD
Hydroxyurea—Skin disorder—Doxorubicin—testicular cancer	0.000266	0.000293	CcSEcCtD
Hydroxyurea—Dyspnoea—Epirubicin—testicular cancer	0.000263	0.00029	CcSEcCtD
Hydroxyurea—Somnolence—Epirubicin—testicular cancer	0.000263	0.000289	CcSEcCtD
Hydroxyurea—Anorexia—Doxorubicin—testicular cancer	0.000261	0.000287	CcSEcCtD
Hydroxyurea—Feeling abnormal—Methotrexate—testicular cancer	0.00026	0.000287	CcSEcCtD
Hydroxyurea—Dyspepsia—Epirubicin—testicular cancer	0.00026	0.000287	CcSEcCtD
Hydroxyurea—Decreased appetite—Epirubicin—testicular cancer	0.000257	0.000283	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000255	0.000281	CcSEcCtD
Hydroxyurea—Fatigue—Epirubicin—testicular cancer	0.000255	0.000281	CcSEcCtD
Hydroxyurea—Pain—Epirubicin—testicular cancer	0.000253	0.000278	CcSEcCtD
Hydroxyurea—Constipation—Epirubicin—testicular cancer	0.000253	0.000278	CcSEcCtD
Hydroxyurea—Body temperature increased—Methotrexate—testicular cancer	0.00025	0.000275	CcSEcCtD
Hydroxyurea—Dyspnoea—Doxorubicin—testicular cancer	0.000244	0.000269	CcSEcCtD
Hydroxyurea—Feeling abnormal—Epirubicin—testicular cancer	0.000244	0.000268	CcSEcCtD
Hydroxyurea—Somnolence—Doxorubicin—testicular cancer	0.000243	0.000268	CcSEcCtD
Hydroxyurea—Dyspepsia—Doxorubicin—testicular cancer	0.000241	0.000265	CcSEcCtD
Hydroxyurea—Decreased appetite—Doxorubicin—testicular cancer	0.000238	0.000262	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000236	0.00026	CcSEcCtD
Hydroxyurea—Fatigue—Doxorubicin—testicular cancer	0.000236	0.00026	CcSEcCtD
Hydroxyurea—Pain—Doxorubicin—testicular cancer	0.000234	0.000258	CcSEcCtD
Hydroxyurea—Constipation—Doxorubicin—testicular cancer	0.000234	0.000258	CcSEcCtD
Hydroxyurea—Body temperature increased—Epirubicin—testicular cancer	0.000234	0.000257	CcSEcCtD
Hydroxyurea—Hypersensitivity—Methotrexate—testicular cancer	0.000233	0.000256	CcSEcCtD
Hydroxyurea—Asthenia—Methotrexate—testicular cancer	0.000227	0.00025	CcSEcCtD
Hydroxyurea—Feeling abnormal—Doxorubicin—testicular cancer	0.000225	0.000248	CcSEcCtD
Hydroxyurea—Hypersensitivity—Epirubicin—testicular cancer	0.000218	0.00024	CcSEcCtD
Hydroxyurea—Body temperature increased—Doxorubicin—testicular cancer	0.000216	0.000238	CcSEcCtD
Hydroxyurea—Diarrhoea—Methotrexate—testicular cancer	0.000216	0.000238	CcSEcCtD
Hydroxyurea—Asthenia—Epirubicin—testicular cancer	0.000212	0.000234	CcSEcCtD
Hydroxyurea—Dizziness—Methotrexate—testicular cancer	0.000209	0.00023	CcSEcCtD
Hydroxyurea—Diarrhoea—Epirubicin—testicular cancer	0.000202	0.000223	CcSEcCtD
Hydroxyurea—Hypersensitivity—Doxorubicin—testicular cancer	0.000201	0.000222	CcSEcCtD
Hydroxyurea—Vomiting—Methotrexate—testicular cancer	0.000201	0.000221	CcSEcCtD
Hydroxyurea—Rash—Methotrexate—testicular cancer	0.000199	0.000219	CcSEcCtD
Hydroxyurea—Dermatitis—Methotrexate—testicular cancer	0.000199	0.000219	CcSEcCtD
Hydroxyurea—Headache—Methotrexate—testicular cancer	0.000198	0.000218	CcSEcCtD
Hydroxyurea—Asthenia—Doxorubicin—testicular cancer	0.000196	0.000216	CcSEcCtD
Hydroxyurea—Dizziness—Epirubicin—testicular cancer	0.000195	0.000215	CcSEcCtD
Hydroxyurea—Vomiting—Epirubicin—testicular cancer	0.000188	0.000207	CcSEcCtD
Hydroxyurea—Nausea—Methotrexate—testicular cancer	0.000188	0.000207	CcSEcCtD
Hydroxyurea—Diarrhoea—Doxorubicin—testicular cancer	0.000187	0.000206	CcSEcCtD
Hydroxyurea—Rash—Epirubicin—testicular cancer	0.000186	0.000205	CcSEcCtD
Hydroxyurea—Dermatitis—Epirubicin—testicular cancer	0.000186	0.000205	CcSEcCtD
Hydroxyurea—Headache—Epirubicin—testicular cancer	0.000185	0.000204	CcSEcCtD
Hydroxyurea—Dizziness—Doxorubicin—testicular cancer	0.000181	0.000199	CcSEcCtD
Hydroxyurea—Nausea—Epirubicin—testicular cancer	0.000176	0.000193	CcSEcCtD
Hydroxyurea—Vomiting—Doxorubicin—testicular cancer	0.000174	0.000192	CcSEcCtD
Hydroxyurea—Rash—Doxorubicin—testicular cancer	0.000172	0.00019	CcSEcCtD
Hydroxyurea—Dermatitis—Doxorubicin—testicular cancer	0.000172	0.00019	CcSEcCtD
Hydroxyurea—Headache—Doxorubicin—testicular cancer	0.000171	0.000189	CcSEcCtD
Hydroxyurea—Nausea—Doxorubicin—testicular cancer	0.000162	0.000179	CcSEcCtD
